Share. Connect. Create. Grow. · Socialiya
Novo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline

Novo Nordisk shares fell after its experimental medicine, ziltivekimab, failed to show a statistical...

BUSINESS NEWS July 31, 2026

Novo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline

Novo Nordisk shares fell after its experimental medicine, ziltivekimab, failed to show a statistically meaningful reduction in major adverse cardiovascular...

11 views 0 likes 0 comments
Share:
Novo Nordisk shares fell after its experimental medicine, ziltivekimab, failed to show a statistically meaningful reduction in major adverse cardiovascular...

Related News

Latest News

Advertisement

Top Categories

Advertisement
Advertisement
Advertisement
Advertisement